Whittier Trust’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $170K | Hold |
262
| – | – | ﹤0.01% | 656 |
|
|
2026
Q1 | $200K | Sell |
262
-95
| -27% | -$72.7K | ﹤0.01% | 595 |
|
|
2025
Q4 | $277K | Buy |
357
+20
| +6% | +$13.6K | ﹤0.01% | 543 |
|
|
2025
Q3 | $202K | Sell |
337
-3
| -0.9% | -$1.7K | ﹤0.01% | 588 |
|
|
2025
Q2 | $179K | Sell |
340
-500
| -60% | -$279K | ﹤0.01% | 680 |
|
|
2025
Q1 | $533K | Sell |
840
-23
| -3% | -$15.8K | 0.01% | 474 |
|
|
2024
Q4 | $615K | Buy |
863
+98
| +13% | +$82.2K | 0.01% | 460 |
|
|
2024
Q3 | $804K | Hold |
765
| – | – | 0.01% | 425 |
|
|
2024
Q2 | $804K | Sell |
765
-9
| -1% | -$8.72K | 0.01% | 403 |
|
|
2024
Q1 | $745K | Hold |
774
| – | – | 0.01% | 416 |
|
|
2023
Q4 | $680K | Buy |
774
+486
| +169% | +$400K | 0.01% | 418 |
|
|
2023
Q3 | $237K | Buy |
288
+35
| +14% | +$27.5K | ﹤0.01% | 596 |
|
|
2023
Q2 | $182K | Sell |
253
-2
| -0.8% | -$1.54K | ﹤0.01% | 649 |
|
|
2023
Q1 | $210K | Buy |
255
+88
| +53% | +$66.4K | ﹤0.01% | 645 |
|
|
2022
Q4 | $120K | Hold |
167
| – | – | ﹤0.01% | 767 |
|
|
2022
Q3 | $115K | Sell |
167
-26
| -13% | -$16.4K | ﹤0.01% | 764 |
|
|
2022
Q2 | $114K | Buy |
193
+26
| +16% | +$16.9K | ﹤0.01% | 754 |
|
|
2022
Q1 | $117K | Sell |
167
-12
| -7% | -$7.59K | ﹤0.01% | 789 |
|
|
2021
Q4 | $113K | Buy |
179
+141
| +371% | +$86.7K | ﹤0.01% | 796 |
|
|
2021
Q3 | $23K | Hold |
38
| – | – | ﹤0.01% | 1093 |
|
|
2021
Q2 | $21K | Sell |
38
-17
| -31% | -$8.61K | ﹤0.01% | 1134 |
|
|
2021
Q1 | $26K | Hold |
55
| – | – | ﹤0.01% | 1081 |
|
|
2020
Q4 | $27K | Sell |
55
-14
| -20% | -$7.56K | ﹤0.01% | 976 |
|
|
2020
Q3 | $39K | Sell |
69
-15
| -18% | -$9.1K | ﹤0.01% | 880 |
|
|
2020
Q2 | $53K | Buy |
84
+28
| +50% | +$15.9K | ﹤0.01% | 791 |
|
|
2020
Q1 | $27K | Sell |
56
-24
| -30% | -$9.9K | ﹤0.01% | 923 |
|
|
2019
Q4 | $30K | Sell |
80
-137
| -63% | -$46.1K | ﹤0.01% | 949 |
|
|
2019
Q3 | $60K | Buy |
217
+194
| +843% | +$57.4K | ﹤0.01% | 799 |
|
|
2019
Q2 | $7K | Hold |
23
| – | – | ﹤0.01% | 1122 |
|
|
2019
Q1 | $9K | Sell |
23
-45
| -66% | -$18.5K | ﹤0.01% | 1077 |
|
|
2018
Q4 | $25K | Buy |
68
+45
| +196% | +$16.5K | ﹤0.01% | 914 |
|
|
2018
Q3 | $9K | Hold |
23
| – | – | ﹤0.01% | 1061 |
|
|
2018
Q2 | $8K | Sell |
23
-35
| -60% | -$10.9K | ﹤0.01% | 1048 |
|
|
2018
Q1 | $20K | Hold |
58
| – | – | ﹤0.01% | 938 |
|
|
2017
Q4 | $22K | Sell |
58
-24
| -29% | -$9.72K | ﹤0.01% | 904 |
|
|
2017
Q3 | $37K | Buy |
82
+47
| +134% | +$22.4K | ﹤0.01% | 804 |
|
|
2017
Q2 | $17K | Hold |
35
| – | – | ﹤0.01% | 914 |
|
|
2017
Q1 | $14K | Buy |
+35
| New | +$13K | ﹤0.01% | 947 |
|
|
2016
Q4 | – | Sell |
-26
| Closed | -$10K | – | 1212 |
|
|
2016
Q3 | $10K | Hold |
26
| – | – | ﹤0.01% | 962 |
|
|
2016
Q2 | $9K | Hold |
26
| – | – | ﹤0.01% | 1003 |
|
|
2016
Q1 | $9K | Hold |
26
| – | – | ﹤0.01% | 987 |
|
|
2015
Q4 | $14K | Hold |
26
| – | – | ﹤0.01% | 922 |
|
|
2015
Q3 | $12K | Hold |
26
| – | – | ﹤0.01% | 930 |
|
|
2015
Q2 | $13K | Hold |
26
| – | – | ﹤0.01% | 980 |
|
|
2015
Q1 | $12K | Hold |
26
| – | – | ﹤0.01% | 989 |
|
|
2014
Q4 | $11K | Hold |
26
| – | – | ﹤0.01% | 868 |
|
|
2014
Q3 | $9K | Hold |
26
| – | – | ﹤0.01% | 876 |
|
|
2014
Q2 | $7K | Hold |
26
| – | – | ﹤0.01% | 909 |
|
|
2014
Q1 | $8K | Buy |
+26
| New | +$8.01K | ﹤0.01% | 918 |
|
Other funds holding REGN
Whittier Trust's REGN Position: Q2 2026 in Review
Whittier Trust held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 262 shares worth $170K. The position accounts for ﹤0.01% of the portfolio, ranked #656.
Whittier Trust first reported a position in REGN in Q1 2014 and has held it in 49 quarters since. The position peaked at $804K in Q3 2024. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Whittier Trust held 262 shares of Regeneron Pharmaceuticals worth $170K as of Q2 2026.
- Whittier Trust left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
- Regeneron Pharmaceuticals made up ﹤0.01% of Whittier Trust's portfolio in Q2 2026, its #656 holding.
- Whittier Trust first reported a position in Regeneron Pharmaceuticals in Q1 2014 and has held it in 49 quarters since.
- Whittier Trust's Regeneron Pharmaceuticals position peaked at $804K in Q3 2024.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Whittier Trust's 13F filing for Q2 2026, filed 28 Jul 2026.